Price $11.08 |
Market Cap
44.7M
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
143.3
|
P/B
3.14
|
P/S
167.89
|
Dividend %
-
|
|
P/CF
71.5
|
P/FCF
-
|
Op. Cash Flow
-2.4K
|
FCF
-0.6
|
|
Op. Margin
-246.60%
|
Net Margin
108.50%
|
ROE
2.20%
|
ROI
-2.80%
|
|
ROA
1.90%
|
EPS Growth
126.80%
|
Current Ratio
-
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Anika Therapeutics Inc (ANIK) | $31.99 | - | - | 525.2M | Strong Buy |
| Sensus Healthcare Inc (SRTS) | $7.43 | - | - | 119.8M | Strong Buy |
| Akumin Inc (AKU) | $1.51 | - | - | 184.9M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.63 | - | - | 68.5M | Strong Buy |
| Viatris Inc (VTRS) | $14.53 | - | 3.30% | 16.39B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
